An HIV vaccine could be closer than we think.
A study published in Nature Medicine earlier this month highlights significant progress in efforts by scientists at the National Institutes of Health to develop an HIV vaccine. By targeting a vulnerable part of the virus, scientists were able to elicit antibodies that neutralized almost one-third of HIV strains in mice. The vaccine produced a similar neutralizing response in guinea pigs and rhesus monkeys, suggesting that their approach is promising. The researchers will continue to optimize the vaccine in the coming months, and anticipate beginning a preliminary human trial of the new vaccine regimen in late 2019.
– Anna Katz, Communications Intern